Pharmaceutical combinations of hcv-protease and -ires...

Details Pharmaceutical combinations of hcv-protease and -ires... Pharmaceutical combinations of hcv-protease and -ires...

A - Human Necessities

61

K

A61K 38/06 (2006.01) A61K 31/506 (2006.01) A61K 38/04 (2006.01) A61P 31/14 (2006.01) A61K 38/55 (2006.01)

Patent

CA 2644389

Disclosed are medicaments, pharmaceutical compositions, pharmaceutical kits, and methods based on combinations of: (a) at least one HCV IRES inhibitor; and (b) at least one HCV protease inhibitor; and optionally (c) at least one other therapeutic agent; for concurrent or consecutive administration in treating or ameliorating one or more symptoms of HCV, or disorders associated with HCV in a subject in need thereof.

La présente invention concerne des médicaments, compositions pharmaceutiques, kits pharmaceutiques et procédés basés sur des associations comprenant : (a) au moins un inhibiteur de l'IRES du HCV; et (b) au moins un inhibiteur de la protéase de l'HCV; et facultativement (c) au moins un autre agent thérapeutique; pour une administration concomitante ou séquentielle dans le cadre du traitement ou du soulagement d'un ou plusieurs symptômes de l'HCV, ou des troubles associés au HCV chez un sujet en ayant besoin.

Affiliated with

Also associated with

Rating

Pharmaceutical combinations of hcv-protease and -ires... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical combinations of hcv-protease and -ires..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical combinations of hcv-protease and -ires... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1918583